icon-folder.gif   Conference Reports for NATAP  
 
  Glasgow HIV
28 - 31 October 2018
Glasgow, UK
Back grey_arrow_rt.gif
 
 
 
Efficacy of MK-8591 against diverse HIV-1 subtypes and NRTI-resistant clinical isolates
 
 
  Reported by Jules Levin
Glasgow Oct 28-31 2018
 
J.A. Grobler; Q. Huang; D.J. Hazuda; M.-T. Lai Merck & Co., Inc., Kenilworth, NJ, USA

1031181

1031182

1031183

1031184

1031185

1031186

1031187

1031188

1031189

10311810

10311811

10311812

10311813